DNLI
Price
$14.70
Change
-$0.25 (-1.67%)
Updated
Mar 11, 03:05 PM (EDT)
Capitalization
2.42B
63 days until earnings call
FHTX
Price
$4.36
Change
-$0.04 (-0.91%)
Updated
Mar 11, 03:03 PM (EDT)
Capitalization
244.69M
62 days until earnings call
Ad is loading...

DNLI vs FHTX

Header iconDNLI vs FHTX Comparison
Open Charts DNLI vs FHTXBanner chart's image
Denali Therapeutics
Price$14.70
Change-$0.25 (-1.67%)
Volume$100
Capitalization2.42B
Foghorn Therapeutics
Price$4.36
Change-$0.04 (-0.91%)
Volume$100
Capitalization244.69M
DNLI vs FHTX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. FHTX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (DNLI: $14.95 vs. FHTX: $4.40)
Brand notoriety: DNLI and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 155% vs. FHTX: 76%
Market capitalization -- DNLI: $2.42B vs. FHTX: $244.69M
DNLI [@Biotechnology] is valued at $2.42B. FHTX’s [@Biotechnology] market capitalization is $244.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and FHTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 3 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 6 bearish.
  • FHTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than FHTX.

Price Growth

DNLI (@Biotechnology) experienced а -1.64% price change this week, while FHTX (@Biotechnology) price change was +1.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was -9.29%, and the average quarterly price growth was -8.71%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.42B) has a higher market cap than FHTX($245M). FHTX YTD gains are higher at: -6.780 vs. DNLI (-26.644). FHTX has higher annual earnings (EBITDA): -98.53M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. FHTX (267M). FHTX has less debt than DNLI: FHTX (39.1M) vs DNLI (52.5M). FHTX has higher revenues than DNLI: FHTX (25.5M) vs DNLI (0).
DNLIFHTXDNLI / FHTX
Capitalization2.42B245M989%
EBITDA-496.05M-98.53M503%
Gain YTD-26.644-6.780393%
P/E RatioN/AN/A-
Revenue025.5M-
Total Cash837M267M313%
Total Debt52.5M39.1M134%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIFHTX
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CBLSX10.38N/A
N/A
Allspring Large Cap Value Inst
TWSIX119.99N/A
N/A
American Century Select I
MFVZX17.08N/A
N/A
MassMutual Equity Opports I
ASYLX14.93N/A
N/A
AB Select US Long/Short Advisor
OFIGX11.17N/A
N/A
Oberweis Focused International Gr Fd